Glenmede Trust’s PhenixFIN Corporation 6.125% Senior Notes due 2023 PFXNL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-757
Closed -$18K 2679
2020
Q1
$18K Hold
757
﹤0.01% 2160
2019
Q4
$18K Hold
757
﹤0.01% 2160
2019
Q3
$18 Hold
757
﹤0.01% 2106
2019
Q2
$16 Hold
757
﹤0.01% 2161
2019
Q1
$18 Hold
757
﹤0.01% 2129
2018
Q4
$18 Buy
+757
New +$18.7K ﹤0.01% 2049
2018
Q3
Sell
-874
Closed -$21K 1896
2018
Q2
$21K Sell
874
-126
-13% -$3.14K ﹤0.01% 1710
2018
Q1
$25K Hold
1,000
﹤0.01% 1877
2017
Q4
$25K Hold
1,000
﹤0.01% 1877
2017
Q3
$25K Buy
+1,000
New +$25.3K ﹤0.01% 1898

Glenmede Trust's PFXNL Position: Q2 2020 in Review

Glenmede Trust sold out of PhenixFIN Corporation 6.125% Senior Notes due 2023 (PFXNL) in Q2 2020, closing a stake of 757 shares — an estimated $18K sold.

Glenmede Trust first reported a position in PFXNL in Q3 2017 and held it in 10 quarters. The position peaked at $25K in Q1 2018. 0 funds tracked by Wall St. Rank hold PFXNL as of Q2 2020.

  • Glenmede Trust reported no remaining PhenixFIN Corporation 6.125% Senior Notes due 2023 position as of Q2 2020 after selling out during the quarter.
  • Glenmede Trust sold 757 PhenixFIN Corporation 6.125% Senior Notes due 2023 shares in Q2 2020, an estimated $18K.
  • Glenmede Trust first reported a position in PhenixFIN Corporation 6.125% Senior Notes due 2023 in Q3 2017 and held it in 10 quarters.
  • Glenmede Trust's PhenixFIN Corporation 6.125% Senior Notes due 2023 position peaked at $25K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held PhenixFIN Corporation 6.125% Senior Notes due 2023 as of Q2 2020.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.